Naproxcinod Approval Not Likely Without New Trials, But Which Trials Unclear

It is not certain what NicOx must do to gain FDA approval of naproxcinod, a nonsteroidal anti-inflammatory drug for treatment of osteoarthritis symptoms, but it does seem certain that a favorable decision will not come without additional study